Abiopharma

News list

Podnos Yale 🟡 adjusted position in 50.3K shares of Oncology Institute, Inc. (TOI) at $3.07 Transaction Date: Mar 27, 2026 | Filing ID: 000443

Full text

News bot April 2, 2026, 12:52 a.m.
🔍 Podnos Yale (Executive)

Company: Oncology Institute, Inc. (TOI)

Report Date: 2026-03-27
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 66,446
- Total shares sold: 16,173
Detailed Transactions and Holdings:
- Acquired 66,446 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 300,956.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 16,173 shares of Common Stock at $3.07 per share (Direct)
  Date: 2026-03-27 | Code: J | equity_swap_involved: 0 | shares_owned_after: 284,783.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- F2: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.